We examine the role of BATF3-dependent CD103+ DCs in models of mucosal and systemic bacterial infection and investigate how BATF3-dependent DCs contribute to T-cell-driven immunity to bacteria and to anti-tumor immunity. This evidence concerns the gene BATF3 and neoplasm.